Literature DB >> 15956867

Situational analysis of dietary challenges of the treatment regimen for children and adolescents with phenylketonuria and their primary caregivers.

Carolyn E Ievers-Landis1, Ahna L Hoff, Caitlin Brez, Mary Kathryn Cancilliere, Judy McConnell, Douglas Kerr.   

Abstract

A situational analysis was conducted to evaluate challenges with the treatment regimen (a low protein diet and special supplemental formula) for children and adolescents with phenylketonuria (PKU) and their caregivers. A semistructured interview was administered to 19 caregivers and 11 children with PKU to describe formula and dietary problems and their frequency, difficulty, and affective intensity. Information was also gathered on attempted solutions to problems and their perceived effectiveness. Caregivers who rated dietary problems as less frequent, difficult, and emotionally upsetting and strategies as more effective for solving problems had children with significantly lower phenylalanine (Phe) levels, a biological indicator of adherence (i.e., better adherence; all p values <.05). Caregivers who reported using strategies coded as representing an authoritarian parenting style to solve dietary problems were significantly more likely to have lower household incomes and older children with higher Phe levels than were those who did not report such strategies (all p values <.05).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956867     DOI: 10.1097/00004703-200506000-00004

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  8 in total

1.  Dietary protein counting as an alternative way of maintaining metabolic control in phenylketonuria.

Authors:  A L Sweeney; R M Roberts; J M Fletcher
Journal:  JIMD Rep       Date:  2011-09-16

2.  Demographic and Psychosocial Influences on Treatment Adherence for Children and Adolescents with PKU: A Systematic Review.

Authors:  Emma Medford; Dougal Julian Hare; Anja Wittkowski
Journal:  JIMD Rep       Date:  2017-08-25

Review 3.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

4.  Child and family experiences with inborn errors of metabolism: a qualitative interview study with representatives of patient groups.

Authors:  Sara D Khangura; Kylie Tingley; Pranesh Chakraborty; Doug Coyle; Jonathan B Kronick; Anne-Marie Laberge; Julian Little; Fiona A Miller; John J Mitchell; Chitra Prasad; Shabnaz Siddiq; Komudi Siriwardena; Rebecca Sparkes; Kathy N Speechley; Sylvia Stockler; Yannis Trakadis; Brenda J Wilson; Kumanan Wilson; Beth K Potter
Journal:  J Inherit Metab Dis       Date:  2015-07-25       Impact factor: 4.982

5.  Phone-based motivational interviewing to increase self-efficacy in individuals with phenylketonuria.

Authors:  Krista S Viau; Jessica L Jones; Maureen A Murtaugh; Lisa H Gren; Joseph B Stanford; Deborah A Bilder
Journal:  Mol Genet Metab Rep       Date:  2016-01-18

6.  Development of an inventory to assess perceived barriers related to PKU treatment.

Authors:  Katia Irie Teruya; Eduardo Remor; Ida Vanessa Doederlein Schwartz
Journal:  J Patient Rep Outcomes       Date:  2020-05-01

7.  Requirements for a minimum standard of care for phenylketonuria: the patients' perspective.

Authors:  Tobias S Hagedorn; Paul van Berkel; Gregor Hammerschmidt; Markéta Lhotáková; Rosalia Pasqual Saludes
Journal:  Orphanet J Rare Dis       Date:  2013-12-17       Impact factor: 4.123

8.  Choosing between medical management and liver transplant in urea cycle disorders: A conceptual framework for parental treatment decision-making in rare disease.

Authors:  Maya T Gerstein; Anne R Markus; Kan Z Gianattasio; Cynthia Le Mons; Janice Bartos; David M Stevens; Nicholas Ah Mew
Journal:  J Inherit Metab Dis       Date:  2020-01-13       Impact factor: 4.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.